On Monday, Dyne Therapeutics Inc (NASDAQ: DYN) opened lower -9.48% from the last session, before settling in for the closing price of $13.61. Price fluctuations for DYN have ranged from $12.87 to $47.45 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -6.72% at the time writing. With a float of $75.60 million, this company’s outstanding shares have now reached $102.32 million.
Let’s determine the extent of company efficiency that accounts for 191 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Dyne Therapeutics Inc (DYN) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Dyne Therapeutics Inc is 25.71%, while institutional ownership is 90.09%. The most recent insider transaction that took place on Feb 18 ’25, was worth 36,242. In this transaction Chief Scientific Officer of this company sold 2,598 shares at a rate of $13.95, taking the stock ownership to the 199,087 shares. Before that another transaction happened on Feb 18 ’25, when Company’s SVP, Head of Finance & Admin. sold 2,488 for $13.95, making the entire transaction worth $34,708. This insider now owns 124,590 shares in total.
Dyne Therapeutics Inc (DYN) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.87 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -6.72% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 3.75% during the next five years compared to -59.45% drop over the previous five years of trading.
Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators
Check out the current performance indicators for Dyne Therapeutics Inc (DYN). In the past quarter, the stock posted a quick ratio of 15.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.35, a number that is poised to hit -0.88 in the next quarter and is forecasted to reach -3.81 in one year’s time.
Technical Analysis of Dyne Therapeutics Inc (DYN)
Looking closely at Dyne Therapeutics Inc (NASDAQ: DYN), its last 5-days average volume was 1.72 million, which is a drop from its year-to-date volume of 2.26 million. As of the previous 9 days, the stock’s Stochastic %D was 18.10%. Additionally, its Average True Range was 1.02.
During the past 100 days, Dyne Therapeutics Inc’s (DYN) raw stochastic average was set at 0.17%, which indicates a significant decrease from 1.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.21% in the past 14 days, which was lower than the 85.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.23, while its 200-day Moving Average is $30.44. However, in the short run, Dyne Therapeutics Inc’s stock first resistance to watch stands at $13.25. Second resistance stands at $14.19. The third major resistance level sits at $14.67. If the price goes on to break the first support level at $11.83, it is likely to go to the next support level at $11.35. Now, if the price goes above the second support level, the third support stands at $10.41.
Dyne Therapeutics Inc (NASDAQ: DYN) Key Stats
There are currently 101,766K shares outstanding in the company with a market cap of 1.39 billion. Presently, the company’s annual sales total 0 K according to its annual income of -235,940 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -97,130 K.
